Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1986 Nov;70(11):804–807. doi: 10.1136/bjo.70.11.804

Ophthalmic survey of a diabetic clinic: II. Requirements for treatment of retinopathy.

R H Grey, A Morris
PMCID: PMC1040832  PMID: 3790480

Abstract

The eyes of 658 patients attending a district general hospital diabetic clinic were examined for retinopathy requiring treatment by photocoagulation or vitreoretinal surgery. Although the majority of patients with serious retinopathy were already under ophthalmic supervision, 39 cases (52 eyes) were found which required treatment. Eighty eyes had had previous photocoagulation, and treatment was recommended for maculopathy in 40 eyes, proliferative retinopathy in seven eyes, and combined maculopathy and proliferative retinopathy in five eyes. This suggested that existing referral criteria for photocoagulation in the population studied were reasonably accurate for proliferative retinopathy, but maculopathy was more frequently overlooked. In insulin dependent patients (IDDs) undetected maculopathy was found in 17/416 eyes, (4.0%) and in non-insulin dependent patients (NIDDs) 28/899 (3.1%). Untreated proliferative retinopathy was discovered in 5/416 (1.2%) IDD eyes and 7/899 (0.8%) of NIDD eyes. Vitreoretinal surgery was required in six eyes (0.5%) for vitreous haemorrhage or traction retinal detachment. Equipment for the treatment of diabetic retinopathy is now almost universally available in ophthalmic departments, but time for patient management by trained staff may be inadequate. Each UK ophthalmic consultant needs approximately 100 sessions per year to monitor and treat known cases of retinopathy apart from time required to train junior staff.

Full text

PDF
804

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaberg T. M. Clinical results in vitrectomy for diabetic traction retinal detachment. Am J Ophthalmol. 1979 Aug;88(2):246–253. doi: 10.1016/0002-9394(79)90473-2. [DOI] [PubMed] [Google Scholar]
  2. Boase D. L., Blach R. K., Fison L. G., Leaver P. K., McLeod D. Results of closed vitrectomy. Trans Ophthalmol Soc U K. 1977 Jul;97(2):251–253. [PubMed] [Google Scholar]
  3. Cheng H. Response of proliferative diabetic retinopathy to xenon-arc photocoagulation. A multicentre randomized controlled trial. Second interim report. Trans Ophthalmol Soc U K. 1976 Jul;96(2):224–227. [PubMed] [Google Scholar]
  4. Grey R. H., Malcolm N., O'Reilly D., Morris A. Ophthalmic survey of a diabetic clinic. I: Ocular findings. Br J Ophthalmol. 1986 Nov;70(11):797–803. doi: 10.1136/bjo.70.11.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hamilton A. M., Townsend C., Khoury D., Gould E., Blach R. K. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 1. Effect on disc vessels, visual fields, and visual acuity. Trans Ophthalmol Soc U K. 1981;101(1):87–92. [PubMed] [Google Scholar]
  6. Hercules B. L., Gayed I. I., Lucas S. B., Jeacock J. Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy: a three-year interim report of a randomised, controlled study using the argon laser. Br J Ophthalmol. 1977 Sep;61(9):555–563. doi: 10.1136/bjo.61.9.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Michels R. G., Rice T. A., Rice E. F. Vitrectomy for diabetic vitreous hemorrhage. Am J Ophthalmol. 1983 Jan;95(1):12–21. doi: 10.1016/0002-9394(83)90329-x. [DOI] [PubMed] [Google Scholar]
  8. Michels R. G. Vitrectomy for complications of diabetic retinopathy. Arch Ophthalmol. 1978 Feb;96(2):237–246. doi: 10.1001/archopht.1978.03910050105001. [DOI] [PubMed] [Google Scholar]
  9. Reeser F., Fleischman J., Williams G. A., Goldman A. Efficacy of argon laser photocoagulation in the treatment of circinate diabetic retinopathy. Am J Ophthalmol. 1981 Dec;92(6):762–767. doi: 10.1016/s0002-9394(14)75626-0. [DOI] [PubMed] [Google Scholar]
  10. Rice T. A., Michels R. G., Rice E. F. Vitrectomy for diabetic traction retinal detachment involving the macula. Am J Ophthalmol. 1983 Jan;95(1):22–33. doi: 10.1016/0002-9394(83)90330-6. [DOI] [PubMed] [Google Scholar]
  11. Scobie I. N., MacCuish A. C., Barrie T., Green F. D., Foulds W. S. Serious retinopathy in a diabetic clinic: prevalence and therapeutic implications. Lancet. 1981 Sep 5;2(8245):520–521. doi: 10.1016/s0140-6736(81)90898-9. [DOI] [PubMed] [Google Scholar]
  12. Shea M. Early vitrectomy in proliferative diabetic retinopathy. Arch Ophthalmol. 1983 Aug;101(8):1204–1205. doi: 10.1001/archopht.1983.01040020206006. [DOI] [PubMed] [Google Scholar]
  13. Townsend C., Bailey J., Kohner E. Xenon arc photocoagulation for the treatment of diabetic maculopathy. Interim report of a multicentre controlled clinical study. Br J Ophthalmol. 1980 Jun;64(6):385–391. doi: 10.1136/bjo.64.6.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Whitelocke R. A., Kearns M., Blach R. K., Hamilton A. M. The diabetic maculopathies. Trans Ophthalmol Soc U K. 1979 Jul;99(2):314–320. [PubMed] [Google Scholar]
  15. Yassur Y., Pickle L. W., Fine S. L., Singerman L., Orth D. H., Patz A. Optic disc neovascularisation in diabetic retinopathy: II. Natural history and results of photocoagulation treatment. Br J Ophthalmol. 1980 Feb;64(2):77–86. doi: 10.1136/bjo.64.2.77. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES